Intra-Tympanic Steroid Injections Offered at Fauquier ENT

Intra-tympanic steroid injections are offered at Fauquier ENT. This treatment modality is used in patients with sudden sensorineural hearing loss that responds minimally or not at all to systemic steroids (ie, prednisone). This treatment may be used without systemic steroids trial if there are contraindications to systemic steroid use such as intestinal ulcers and diabetes. The downside is that this treatment works best only if given within the first 36 days after the hearing loss occurs.

Intra-tympanic steroid injections have also been found to potentially help certain patients with tinnitus.

References
• Intratympanic corticosteroids for Meniere's disease and vertigo. Otolarngol Clin N Am. 37:955-972. 2004 Link
• Intratympanic perfusion for the treatment of tinnitus. Otolaryngol Clin N Am. 37:991-1000. 2004 Link
• Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin N Am. 1061-1074. 2004 Link
• Intratympanic Dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 117:3-15. 2007. Link
• Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg. 133:251-59. Link
• Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg. 141:572-578. Link
• Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 141:579-583. Link